Double attack on tough breast cancer shows promise
Disease control
Completed
This small, completed study tested a combination of two drugs for people with advanced breast cancer linked to specific inherited gene changes (BRCA or HDR defects). The goal was to see if using an immunotherapy drug (pembrolizumab) together with a targeted therapy (olaparib) cou…
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC